collaborators

7 papers

cs.LG2026

OmegAMP: Targeted AMP Discovery via Biologically Informed Generation

Diogo Soares, Leon Hetzel, Paulina Szymczak +6

Deep learning-based antimicrobial peptide (AMP) discovery faces critical challenges such as limited controllability, lack of representations that efficiently model antimicrobial pr…

cs.LG2026

Purely Agent-Driven Black-Box Optimization for Biological Design

Natalie Maus, Yimeng Zeng, Haydn Thomas Jones +11

Many key challenges in biological design -- such as small-molecule drug discovery, antimicrobial peptide development, and protein engineering -- can be framed as black-box optimiza…

cs.LG2026

PepCompass: Navigating peptide embedding spaces using Riemannian Geometry

Marcin Możejko, Adam Bielecki, Jurand PrÄ dzyński +10

Antimicrobial peptide discovery is challenged by the astronomical size of peptide space and the relative scarcity of active peptides. Generative models provide continuous latent "m…

cs.LG2025

A deep reinforcement learning platform for antibiotic discovery

Hanqun Cao, Marcelo D. T. Torres, Jingjie Zhang +8

Antimicrobial resistance (AMR) is projected to cause up to 10 million deaths annually by 2050, underscoring the urgent need for new antibiotics. Here we present ApexAmphion, a deep…

cs.LG2025

A Dataset for Distilling Knowledge Priors from Literature for Therapeutic Design

Haydn Thomas Jones, Natalie Maus, Josh Magnus Ludan +9

AI-driven discovery can greatly reduce design time and enhance new therapeutics' effectiveness. Models using simulators explore broad design spaces but risk violating implicit cons…

cs.LG2025

Predicting and generating antibiotics against future pathogens with ApexOracle

Tianang Leng, Fangping Wan, Marcelo Der Torossian Torres +1

Antimicrobial resistance (AMR) is escalating and outpacing current antibiotic development. Thus, discovering antibiotics effective against emerging pathogens is becoming increasing…